ATE449332T1 - Alterungsbiomarker - Google Patents

Alterungsbiomarker

Info

Publication number
ATE449332T1
ATE449332T1 AT05810922T AT05810922T ATE449332T1 AT E449332 T1 ATE449332 T1 AT E449332T1 AT 05810922 T AT05810922 T AT 05810922T AT 05810922 T AT05810922 T AT 05810922T AT E449332 T1 ATE449332 T1 AT E449332T1
Authority
AT
Austria
Prior art keywords
aging
biomarrkers
relates
present
virtual age
Prior art date
Application number
AT05810922T
Other languages
English (en)
Inventor
Cuiying Chen
Roland Contreras
Original Assignee
Vib Vzw
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vib Vzw, Univ Gent filed Critical Vib Vzw
Application granted granted Critical
Publication of ATE449332T1 publication Critical patent/ATE449332T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4722—Proteoglycans, e.g. aggreccan
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
AT05810922T 2004-12-01 2005-11-29 Alterungsbiomarker ATE449332T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106221 2004-12-01
PCT/EP2005/056299 WO2006058878A1 (en) 2004-12-01 2005-11-29 Aging biomarker

Publications (1)

Publication Number Publication Date
ATE449332T1 true ATE449332T1 (de) 2009-12-15

Family

ID=35645651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810922T ATE449332T1 (de) 2004-12-01 2005-11-29 Alterungsbiomarker

Country Status (6)

Country Link
US (1) US7993822B2 (de)
EP (1) EP1825259B1 (de)
AT (1) ATE449332T1 (de)
CA (1) CA2589247A1 (de)
DE (1) DE602005017817D1 (de)
WO (1) WO2006058878A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011632A (es) * 2006-03-17 2008-10-17 Vib Vzw Vacuna novedosa contra infeccion de trypanosoma cruzi.
US8195880B2 (en) * 2009-04-15 2012-06-05 International Business Machines Corporation Information handling system with immediate scheduling of load operations in a dual-bank cache with dual dispatch into write/read data flow
HRPK20130568B3 (hr) * 2013-06-20 2016-01-29 Genos D.O.O. Postupak analize n-glikana vezanih na imunoglobulin g iz krvne plazme ljudi i njegova upotreba
CN105259346A (zh) * 2015-05-12 2016-01-20 先思达（南京）生物科技有限公司 一种老龄化的生物标记检测方法
EP3199522A1 (de) 2016-02-01 2017-08-02 Solvay SA Aminothioatderivate, herstellung davon und verwendung
WO2023064592A1 (en) * 2021-10-14 2023-04-20 The Regents Of The University Of California Glycan age prediction model

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326209B1 (en) * 2000-01-07 2001-12-04 Univera Pharmaceuticals, Inc. Measurement and quantification of 17 ketosteroid-sulfates as a biomarker of biological age
CA2482686C (en) * 2002-04-16 2012-04-03 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A marker for measuring liver cirrhosis
CA2513250C (en) * 2003-01-14 2017-05-09 Vib Vzw A serum marker for measuring liver fibrosis

Also Published As

Publication number Publication date
CA2589247A1 (en) 2006-06-08
US20080003180A1 (en) 2008-01-03
WO2006058878A1 (en) 2006-06-08
DE602005017817D1 (de) 2009-12-31
EP1825259A1 (de) 2007-08-29
EP1825259B1 (de) 2009-11-18
US7993822B2 (en) 2011-08-09

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
NO20091064L (no) Antistoffer mot IL-17A
WO2017040930A3 (en) Biomarkers predictive of cytokine release syndrome
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
BRPI0519391A2 (pt) mÉtodo para promover a saéde oral em um animal, kit adequado para administraÇço de um ou mais antioxidantes a um animal, dispositivo para transmitir informaÇço ou instruÇÕes, e, uso de uma composiÇço
CU24058B1 (es) Antagonistas de pcsk9
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
NO20076687L (no) Oral doseringsform
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
DE602006018689D1 (de) Inline Gefässversiegelungs- und trennungsinstrument
MX2008006580A (es) Composicion de cereal que comprende edulcorante de alta potencia
DK1809123T3 (da) Dimensionsstabilt foder til selskabsdyr med lavt indhold af carbohydrat
ATE449332T1 (de) Alterungsbiomarker
BRPI0506888A (pt) composições de suplemento lìquido compreendendo um ou mais medicamentos
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
DK2129391T3 (da) Diagnostisk fremgangsmåde
DK1753512T3 (da) Tetrahydropyridothiophener
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
MX341064B (es) Variantes de la familia il-1.
BR112015027249A2 (pt) método de diagnóstico de câncer
ATE541855T1 (de) Weitere kristalline formen von rostafuroxin
WO2011158016A3 (en) Assay

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties